Who owns UNITY BIOTECHNOLOGY, INC.?
- Ticker: UBX
- CUSIP Number: 91381u200
Tip: Access positions for across all investors
Analyze quarterly positions in Unity Biotechnology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Unity Biotechnology stock
Who bought or sold UNITY BIOTECHNOLOGY, INC. this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Alyeska Investment Group | 2.3M | $4.5M | 76% | Dec 2023 |
|
Arch Venture Corp | 1.0M | $1.9M | 0% | Dec 2023 |
|
Vanguard Group | 562k | $1.1M | 0% | Dec 2023 |
|
Citadel Advisors | 68k | $131k | 27% | Dec 2023 |
|
Founders Fund V Management | 49k | $95M | 0% | Dec 2023 |
|
Wells Fargo & Company | 44k | $84k | 0% | Dec 2023 |
|
Cercano Management | 41k | $80k | 0% | Dec 2023 |
|
Jane Street | 29k | $55k | 66% | Dec 2023 |
|
Dimensional Fund Advisors | 26k | $49k | -36% | Dec 2023 |
|
Commonwealth Equity Services | 25k | $40k | 4% | Mar 2024 |
|
Laurion Capital Management | 22k | $42k | -69% | Dec 2023 |
|
Susquehanna International | 16k | $27k | -75% | Mar 2024 |
|
Millennium Management | 13k | $26k | 100% | Dec 2023 |
|
Advisor Group Holdings | 13k | $26k | -43% | Dec 2023 |
|
Wolverine Trading | 11k | $20k | -39% | Dec 2023 |
|
UBS Group | 9.3k | $18k | 2483% | Dec 2023 |
|
Simplex Trading | 1.6k | $2.0k | -30% | Mar 2024 |
|
Royal Bank of Canada | 461.00 | $1.4k | -76% | Dec 2023 |
|
Cape Investment Advisory | 300.00 | $579.000000 | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 257.00 | $496.010000 | 2% | Dec 2023 |
|
Signature | 200.00 | $328.000000 | 0% | Mar 2024 |
|
Rhumbline Advisers | 129.00 | $248.002500 | 0% | Dec 2023 |
|
Carmichael Hill & Associates | 100.00 | $164.000000 | 0% | Mar 2024 |
|
Summit Investment Advisors | 100.00 | $193.000000 | 0% | Dec 2023 |
|
AllSquare Wealth Management | 55.00 | $90.002000 | 0% | Mar 2024 |
|
Bank of America Corporation | 8.00 | $15.000000 | 100% | Dec 2023 |
|